Join the DDA or

Mefenamic acid single batch recall

Film problems with Quadrant product

May 18th 2022

Tagged: MHRA alert

By MHRA

Quadrant Pharmaceuticals Ltd is recalling a specific batch of mefenamic acid 500mg film-coated tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets. This has resulted in the tablet core being partially exposed.

 The affected batch is as follows:

Batch numberCompany’s ReferenceExpiry datePack sizeFirst distributed
1070826949U04/20233003/2022

Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

For more information, medical or supply enquiries, please contact [email protected] or [email protected]